Approvals and safety

Chemically synthesised semaglutide HD1916 met equivalence with Wegovy for weight loss in Chinese adults

A 44-week open-label phase III trial in 462 Chinese adults with obesity found HD1916 equivalent to reference semaglutide for body weight reduction, with similar adverse events.